Atlas Trials

Advanced Accelerator Applications

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Advanced Accelerator Applications

RecordFirmDate
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs (NCT04711135)Advanced Accelerator Applications2022-08-31
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients (NCT04524442)Advanced Accelerator Applications2021-01-25
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NCT03972488)Advanced Accelerator Applications2020-01-08
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake (NCT03872778)Advanced Accelerator Applications2019-07-24
Post-Authorization Long-Term Safety Study of LUTATHERA (NCT03691064)Advanced Accelerator Applications2018-11-28
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) (NCT03724253)Advanced Accelerator Applications2018-07-03
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer (NCT03490838)Advanced Accelerator Applications2018-05-24
68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) (NCT03490032)Advanced Accelerator Applications2018-05-23
99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis (NCT03232580)Advanced Accelerator Applications2017-09-18

Track Advanced Accelerator Applications automatically

Every clearance here is in the API, with alerts when new ones post.